OBALON THERAPEUTICS INC's ticker is OBLN and the CUSIP is 67424L100. A total of 62 filers reported holding OBALON THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $72,000 | -59.3% | 26,837 | -67.4% | 0.00% | – |
| Q2 2018 | $177,000 | +247.1% | 82,333 | +450.7% | 0.00% | – |
| Q1 2018 | $51,000 | -95.3% | 14,951 | -86.9% | 0.00% | -100.0% |
| Q3 2017 | $1,085,000 | -54.1% | 113,900 | -52.3% | 0.00% | -50.0% |
| Q2 2017 | $2,364,000 | -42.4% | 238,543 | -37.8% | 0.00% | -50.0% |
| Q1 2017 | $4,101,000 | +43.1% | 383,600 | +18.5% | 0.01% | +33.3% |
| Q4 2016 | $2,865,000 | – | 323,683 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|